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ABSTRACT 
CORONARY BLOOD FLOW 
AND THE 
PATHOGENESIS OF CATECHOLAMINE CARDIOMYOPATHY 
Michael Simons 
1984 
Norepinephrine (NE) causes extensive myocardial injury in 
the rabbit. To investigate a potential mechanism, coronary 
blood flow (CBF) was measured with radioactive microspheres. 
Coronary resistance (CR) and oxygen demand (HR-BP double 
product) were calculated. Severity of injury was determined 
by semiquantative histological evaluation. Changes 
resulting from NE infusion were determined in animals with 
or without alpha receptor blockade with phentolamine (Ph, 
lOmg). In all animals oxygen demand remained constant. CBF 
(ml/g/min), was 2.66 at the beginning of the experiment, 
rose to 3.46 after 3 minutes of NE infusion (p < 0.05), then 
declined to baseline values, (2.33) after 10 minutes. 
However, CBF was sharply lower than baseline (1.51; p < 
0.05) after 40 minutes of infusion. CR rose progressively 
from baseline values of 40.9 (units) to 74.8 at 40 minutes 
(p < 0.05). Animals given Ph manifested none of these 
changes. Saline-infused controls showed no significant 
11 

changes in CBF or CR. Animals pretreated with Ph had minimal 
histological damage at 48 hours compared with NE alone (p < 
0.01). It is concluded that NE induces sustained coronary 
vasoconstriction in the rabbit and that reduced CBF may 
contribute to the pathogenesis of NE cardiomyopathy in this 
species. 
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1 
INTRODUCTION 
This thesis deals with the subject of regulation by 
adenosine of transmyocardial coronary flow and the role of 
alterations of such regulation in the pathogenesis of 
catecholamine cardiomyopathy. 
Chapter One reviews the literature on local control of 
coronary flow with a special emphasis on adenosine's role in 
transmural flow distribution. Chapter Two considers the 
subject of catecholamine cardiomyopathy. The pathology and 
pathophysiology of catecholamine injury are reviewed and the 
possible pathogenic mechanisms are discussed. Chapter Three 
reports the experimental study designed to determine if the 
catecholamine-mediated changes in the coronary circulation 
play a role in pathogenesis of this cardiomyopathy. 
It has been established that under normal conditions, as 
well as under conditions of physiological stress (i.e. 
exercise), coronary flow is distributed equally between the 
subendocardial and the subepicardial regions. Since most of 
coronary flow to the endocardium occurs in diastole, some 
adaptive mechanisms must operate in order to assure the 
adequacy and equality of the endocardial perfusion. One 
such mechanism is a relatively higher vascular density in 
the subendocardium resulting in lower subendocardial 
resistance to flow. While this anatomic difference may 
suffice to supply enough blood to the subendocardium during 
resting conditions, it is not adequate during stresses such 
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as exercise or tachycardia. Therefore, one must postulate 
the existence of an active vasomotive agent, capable of 
precise adjustment of the transmyocardial flow distribution. 
Among the many substances proposed for this role adenosine 
appears to be the most likely candidate. 
In Chapters Two and Three we examine the potential role 
of catecholamine-induced coronary flow changes in the 
pathogenesis of catecholamine cardiomyopathy. This form of 
myocardial injury has been well studied morphologically and 
functionally, but its pathogenesis still remains 
controversial. One of the characteristic pathological 
findings in this condition is the predominance of damage in 
the subendocardial areas. Although morphologically the 
injury does not present an ischemic pattern any agent 
inducing damage consequent to a reduction of coronary flow 
would be expected to produce the most pronounced injury in 
the subendocardial regions. Recently it was found that 
alpha-adrenoceptor activation mediates the damage and that 
alpha-blockade effectively prevents its development. Thus 
it can be speculated that norepinephrine induced coronary 
vasoconstriction is responsible for pathogenesis of the 
lesions. 
A number of studies have addressed the question of 
norepinephrine induced coronary flow changes, and the most 
frequent finding is that the coronary flow actually 
increases. It should be noted, however, that these studies 
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were largely concerned with acute effects of norepinephrine 
and no long term infusions were performed. It is, therefore, 
possible that a longer term exposure to norepinephrine might 
actually decrease coronary flow. The reason why a short term 
infusion would result in increased flow while a long term 
one reduces the flow may lie with the interaction of 
norepinephrine with adenosine. 
Adenosine is known to counteract many of the myocardial 
effects of catecholamines. Furthermore, norepinephrine 
administration has been shown to cause adenosine release by 
myocardium. Thus, norepinephrine induced adenosine release 
could potentially override the vasoconstrictor effects of 
the amine and result in increased coronary flow. This would 
explain the finding in studies dealing with short term 
norepinephrine infusion. However, long term infusion of 
norepinephrine results in a significant reduction of 
coronary blood flow, as was found in the present study. 
This may in part be due to loss of the protective effect of 
adenosine. 
■ ‘M: 
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CHAPTER ONE 
LOCAL CONTROL OF TRANSMYOCARDIAL CORONARY BLOOD FLOW 
1 Funcional Anatomy of the Coronary Circulation 
The major coronary vessels pass on the epicardial surface 
of the heart from the AV ring to the apex. They divide on 
the epicardial surface, and after reaching the diameter of 3 
mm, begin to give off branches at right angles into the 
myocardium. These penetrating branches have the diameter of 
400 to 1500 micron and fall into two general classes: class 
A and class B (1, 2). Class A vessels quickly branch into a 
very fine network which is distributed in the outer 3/4 to 
4/5 of the myocardium. Class B vessels are less numerous, 
branch infrequently and reach the inner layers of the 
myocardium with no reduction in size. In the subendocardial 
layer these vessels subdivide forming a large meshwork of 
anastomoses. Therefore, this large endocardial plexus is 
supplied at multiple points by class B vessels derived 
directly from epicardial vessels. 
Class B vessels of the subendocardial plexus typically 
range in size from 50 to 500 microns, with occasional 
vessels in the plexus reaching the diameter of 1000 microns 
(1). The capillary network thus formed in the myocardium 
has the average density of 4000 capillaries/mm (3). 
Capillaries run parallel to the myocardial fibers, and, as 
viewed in cross-section, there is about one capillary for 
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each fiber. This places each fiber in contact with 3-4 
capillaries (3). Under normal physical conditions not all 
capillaries are open, and additional ones can be recruited 
depending on the myocardial needs (4,5). 
The normal heart possesses some connections between 
distal branches of major coronary arteries. However, these 
anastomoses are insufficient to maintain adequate perfusion 
following a sudden occlusion of a major artery (6). 
An important question arises concerning the ability of 
these anastomoses to maintain some degree of perfusion for a 
certain period of time after an occlusion of a major 
coronary artery. This question has important clinical 
implications, for if such a region at risk ("border zone") 
existed some kind of intervention designed to salvage 
myocardium in this area could be attempted, while if such a 
zone did not exist, nothing short of immediate reperfusion 
would suffice. A considerable controversy has arisen over 
the existence of such a border zone of intermediate injury 
during regional myocardial ischemia. Although a detailed 
review of this subject is beyond the scope of this chapter, 
the subject illustrates well some important aspects of 
methodology as well as of functional anatomy of coronary 
circulation. 
2 Border Zone 
Basically, two possible situations exist. If a major 
coronary artery is suddenly occluded, a zone of ischemia 
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results. Now, going from this zone of ischemia in the 
lateral and transmural planes, one may observe either a 
sharp transition to the normal tissue or, alternatively, a 
zone with intermediate levels of flow, metabolism and 
injury- a border zone. This intermediate zone is thought to 
exist because of collateral circulation from the nonoccluded 
artery, which is sufficient to maintain its viability at 
some intermediate level for a certain period of time. It 
should be pointed right away, that border zone is a spatial 
as well as a temporal category. The existence of a spatial 
border zone would be determined by a variety of anatomic 
factors, while the existence of a temporal border zone is 
dependent on a variety of biochemical changes and the 
dynamic nature of the ischemic process. 
2.1 Spatial considerations 
A large number of studies attempted to demonstrate the 
existense of a border zone lateral to the area of ischemia. 
This was attempted by measuring coronary blood flow, levels 
of ATP, lactate, NAD, as well as P02 and ST segment changes. 
Barlow and Chance (7) used surface fluorescence technigue 
to visualize lateral and transmural gradients of NAD 
reduction. On the basis of the obtained data they postulated 
the existence of a significant border zone. 
Hearse et al. (8) used a specially designed biopsy 
instrument with multiple drill heads to obtain simultaneous 
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multiple transmural biopsy samples. They identified a 8 to 
15 mm boder zone characterized by intermediate levels of 
coronary flow, ATP, creatinine phosphate and lactate 
concentrations. 
Vokonas et al. (9) used 14C- antipyrine radioautography 
to assess regional flow after an acute coronary artery 
occlusion. Twenty micron wide sections were made in 
transverse and transmural planes. Using these methods the 
authors found a 4.5 mm wide border zone of intermediate 
flow. 
Jugdutt et al. (10) used planimetry from "bread loaf" 
sections to calculate the size of infarct area and of the 
border zone wich was found to be of significant size. All 
these studies, however, suffered from a common 
methodological problem, namely that measured intermediate 
levels of metabolites and coronary flow could result not 
only from the existence of cells with truly intermediate 
metabolic states, but also from the coexistence of 
critically injuried cells along- side healthy and viable 
ones. 
It is apparent that a spatial reconstruction of the 
infarct area and the surroundings is necessary to 
distinguish these two possibilities. Factor et al. (11) 
performed serial sections of dog heart 24 hours after 
coronary occlusion reconstructing three dimensional geomety 
of the infarct area using staining techniques. They found 
I 
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that areas of normal tissue in the ischemic zone that used 
to be considered the remaining islands of viable tissue 
supplied by the occluded artery are in fact complex 
interdigating peninsulas of normal tissue supplied by 
another coronary artery invading the ischemic zone. 
Hirzel et al. (12) found no lateral border zone of 
intermediate creatinine kinase depletion 24 hours after 
coronary occlusion in dogs when tissue supplied by non- 
occluded artery was excluded. 
Okun et al. (13) and Factor et al.(14) using colored 
Microfil injections in canine and human hearts respectively, 
found that capillaries derived from one coronary artery form 
descrete loops without interconnection or anastomoses with 
capillaries derived from another coronry artery. Using the 
same technique, Factor et al. (15) found a close correlation 
between the distribution of intramyocardial vasculature and 
the histological myocardial infarction at the infarct margin 
24 hours post occlusion. 
Thus, a firm morphological basis for a sharp lateral 
infarct margin has been established. It has still been 
necessary to demonstrate that functionally this margin was 
also sharp. Yellon et al. (16) used multiple continuous 
biopsy device to assess metabolic changes in transmyocardial 
biopsies. They found no border zone of intermediate 
reduction of metabolism. Murdoch et al. (17) used post 
mortem angiograms to separate regions perfused by occluded 
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and nonoccluded coronary arteries. Three millimiter wide 
sections were obtained. It was found that an itermediate 
reduction in flow occured in a very narrow rim of myocardium 
less than 3 mm wide, immediately inside the ischemic zone, 
and represented an admixture of normal myocardium to the 
ischemic area. 
2.2 Temporal considerations 
It can be considered established that the lateral border 
of an ischemic area is sharp and the observed intermediate 
levels of metabolism and flow are due to the presence of 
peninsulas of viable tissue among the dead cells. However, 
the existence of a transmural border zone is a somewhat 
different matter. Two possible scenarios can be envisioned. 
One possibility is that upon occlusion of a coronary artery 
an entire thickness of the myocardium becomes an area at 
risk and with a passage of time the entire area will 
necrose. Thus, in this model, border zone is exclusively 
time- dependent. Alternatively, a spatially distinct zone of 
cells at risk may exist within the ischemic region. The 
border of this area will, however, move with time (18, 19). 
It is not clear which of these two possibilities is actually 
correct and the question of transmural border zone will 
require further studies. 
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3 Coronary Blood Flow 
The factors determining the overall magnitude of coronary 
blood flow are the perfusion pressure and coronary 
resistance to flow. By analogy with Ohm's Law, coronary 
blood flow is directly proportional to the perfusion 
pressure and inversely proportional to the resistance to 
flow (Q=P/R). We will discuss the factors determining the 
perfusion pressure and flow resistance separately. 
3.1 Perfusion Pressure 
The perfusion pressure responsible for coronary blood 
flow is the pressure gradient between the ostia of the 
coronary arteries and the coronary sinus. The pressure at 
the coronary ostia varies somewhat with the cardiac cycle. 
In systole, ostia are partially occluded by the aortic valve 
leaflets. The effective pressure in the ostia is slightly 
less than the systolic aortic pressure because of Venturri 
effect (20). In diastole aortic pressure (diastolic) is 
effectively transmitted unchanged to the ostia. Obviously, 
any obstruction at the ostia will reduce the perfusion 
pressure. 
The coronary sinus pressure also varies somewhat with the 
heart cycle. Increase in the right atrial pressure leads to 
a decrease in coronary perfusion pressure. It has been 
recently shown that an increase in coronary sinus pressure 
raises the diastolic pressure-zero flow intercept in the 
I 
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subepicardium, while in the subendocardium the pressure-zero 
flow intercept is not changed. This increases the endo/epi 
flow ratio (21). These findings appear to support the 
waterfall model of coronary circulation (see below). 
Interestingly, increase in coronary blood flow due to 
increased perfusion pressure was also shown to result in the 
increased endo/epi flow ratio (22). 
3.2 Resistance to Flow 
The resistance to coronary blood flow can be viewed as a 
sum of two components: resistance due to factors extrinsic 
to the coronary bed and resistance due to factors intrinsic 
to the coronary bed. Factors extrinsic to the coronary bed 
include mechanical deformation of the coronary arteries by 
the myocardium while factors intrinsic to the coronary bed 
include influences affecting the contractile state of smooth 
muscle in the walls of coronary arteries. Each of these two 
resistance components are discussed below. 
Factors Extrinsic to the Coronary Vascular Bed 
The major factor responsible for extrinsic resistance to 
coronary blood flow is myocardial tension in systole. The 
fact that systole affects coronary flow can be dramatically 
illustrated by inducing asystole and observing sudden surge 
in coronary flow (23, 24). Accordingly, a large fraction of 
coronary flow to the left ventricle occurs in diastole. 
Compressive forces in the right ventricle affect the 
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systolic coronary flow to a much leser extent than in the 
left ventricle (25). 
It has been estimated that under resting conditions the 
extrinsic resistance accounts for 25 per cent of the total 
coronary flow resistance (26). Since systole occupies a 
larger portion of the cardiac cycle, it follows that some 
coronary blood flow does take place during systole. Any 
factor that increases the proportion of the cardiac cycle 
occupied by systole relative to diastole will, therefore, 
tend to compromise coronary blood flow. 
Tachicardia, for example, reduces coronary blood flow 
through this mechanism. (Tachicardia also increases a 
myocardial oxygen demand while compromising oxygen 
delivery). Other conditions prolonging systole include 
increased afterload (aortic stenosis, hypertention, etc.), 
decreased contractility, dilatation or hypertrophy. 
Systolic extracoronary resistance. 
Systole can impede coronary flow by two mechanisms: 1) 
development of intramyocardial shearing forces that could 
kink vessels traversing the myocardium and 2) transmission 
of intramyocardial tissue pressure to the vessels. 
As was described in the section dealing with coronary 
vessel anatomy, arteries supplying the endocardial plexus 
take off from epicardial vessels at right angles and go 
straight through the myocardial wall with almost no 
' ^ ’"I I 
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branching. On the other hand, vessels supplying the outer 
one half to two thirds of the myocardial wall branch 
extensively in the epicardial layers after the take off from 
large coronary vessels. Therefore, any deformation of the 
intramyocardial vessels in the midwall will have its 
greatest impact on the subendocardium. 
The LV wall is made of multiple muscle fibers whose 
orientation changes in a rotational manner with the 
myocardial depth (27). It is known that this rotational 
change causes shear strains between the adjacent layers. 
Therefore, it is conceivable that these strains could kink 
or twist arteries passing through the tissue. Downey et al. 
(28) examined effects of shear strains on the systolic 
extravascular resistance. They found that shearing forces 
resulting from systolic shortening accounted for only a 
small fraction of the total resistance, and that effects of 
these shearing forces were distributed uniformly through the 
LV wall, and, therefore, could not account for the systolic 
endo/epi flow gradient. An additional argument against the 
major role of shearing strains comes from studies of Hess 
and Bache on right ventricular systolic flow (25). They 
showed that no transmural flow gradient developed in the 
right ventricular wall when coronary flow was confined to 
systole. Recently, Williams et al (29) examined the 
transmyocardial coronary flow distribution in the empty 
beating heart using low perfusion pressure and maximal 
vasodilation. Such a preparation maximizes systolic strains 
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in the myocardial wall by allowing the heart to contract 
against a zero afterload. They found that a small 
transmural flow gradient which was nowhere near in magnitude 
the gradient developing during systole in normally beating 
hearts contracting against a ventricular pressure. 
Therefore, it is unlikely that systolic shearing strains 
play a significant role in the development of extravascular 
coronary resistance. 
We are left, then, with intramyocardial systolic tissue 
pressure as the major factor accounting for the systolic 
extravascular resistance. It has been conclusively shown 
that when left ventricular coronary flow is restricted to 
systole, a substantial transmural flow gradient develops 
with epicardial flow far exceeding the endocardial flow 
(30-32). Therefore, it is logical to assume the existence 
of a systolic intramyocardial pressure gradient between the 
endocardium and the subepicardium, with subendocardial 
pressures exceeding subepicardial pressures. The magnitude 
of this gradient, however, remanis a subject of considerable 
disagreement. 
Kirk and Honig used the fluid-filled pocket model in 1964 
(33) to find that subendocardial pressure in systole 
exceeded intracavitary systolic pressure. At the same time 
they observed that subepicardial systolic pressure was less 
than intracavitary (and subendocardial) systolic ppressures. 
Brandi and McGregor suggested in 1969 (34) that the 
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introduction of even a small volulme distorts 
intramyocardial tissue architecture, and, therefore, 
different tissue pressure will be obtained with fluid 
pockets of different sizes. By using different rates of 
infusion, creating thereby pockets of varying volumes, and 
measuring intamyocardial pressures at these different pocket 
volumes, they came to the conclusion that extrapolating to 
intramyocardial pressure at zero pocket volume results in 
subendocardial pressure equal to intracavitary pressure in 
systole. They have also found that systolic subepicardial 
pressure was equal to the ambient pressure. Armour and 
Randall used miniature pressure transducers in 1971 (35), 
while Stein et al. used micropressure transducers in 1980 
(36) to obtain systolic subendocardial pressures in excess 
of intracavitary systolic pressure. Although it can still 
be argued that microtransducers distort tissue architecture 
and, therefore, are not very accurate, there is no doubt 
that substantial transmural pressure gradient exists in the 
LV wall with subendocardial pressures likely exceeding 
intracavitary pressure and subepicardial pressures less than 
intracavitray and subendocardial pressures. On the other 
hand, a waterfall theory proposed by Downey and Kirk 
(discussed in detail below) predicts that the magnitude of 
the subendocardial pressure should be very close to the 
interventricular pressure. This prediction was tested 
recently in a study by Munch and Downey (37), who measured 
blood flow to maximally dilated subendocardial vessels under 
:ts. 
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a variety of hemodynamic conditions. They found that a 
waterfall model predicted the value of the subendocardial 
flow accurately when the subendocardial pressure was taken 
to be equal to the intracavitary pressure. On the other 
hand, when the subendocardial pressure was taken to be twice 
the magnnitude of the intracavitary pressure the correlation 
between the observed and predicted subendocardial flow was 
poor (37). 
Diastolic extracoronary resistance The subject of diastolic 
extravascular resistance is less well studied and understood 
than that of systolic resistance. The diastolic 
intramyocardial pressure can be thought of as consisting of 
two components: intrinsic pressure (intramyocardial pressure 
at zero preload) and the pressure transmitted into the 
myocardium from the diastolic chamber pressure (preload 
component) (38). There exists a considerable controversy 
regarding the magnitude of diastolic intramyocardial 
pressure, its transmural distribution and its importance in 
the overall diastolic blood flow regulation. 
While some investigators found that diastolic 
intramyocardial pressure is uniformly distributed through 
the ventricular wall (39), others found a transmyocardial 
pressure gradient with subendocardial pressures exceeding 
subepicardial ones (40,41). Stein et al. (36) used 
implantable pressure microtranducers to find that the 
diastolic subepicardial pressure was higher than 
'■ 'PV 
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subendocardial pressure, which in turn was higher than the 
end-diastolic intracavitary pressure. Therefore, they in 
fact observed a diastolic transmural pressure gradient 
across the myocardial wall, which was opposite in direction 
to the systolic transmural pressure gradient. It is 
important to note that while Stein et al. and Baird et al. 
(36, 39) used direct pressiure measurements, Pao et al. and 
Rouleau et al. (40,41) used such indirect methods as 
pressure-zero flow intercept to estimate the diastolic 
intramyocardial pressure. The difference between direct and 
indirect studies will have to be resolved. 
The relative importance of diastolic extravascular 
resistance versus intravascular resistance is a matter of 
another controversy. Although it is generally assumed that 
the diastolic resistance to coronary blood flow is 
primarilly determined by the coronary vessel tone 
(intravascular resistance), Archie (38) found that diastolic 
extravascular resistance was a major determinant of 
diastolic coronary flow. 
Factors Intrinsic to the Coronary Vascular Bed 
Neural, metabolic, pharmacologic and myogenic factors 
influence the tone of myocardial vessels (42,43). There is 
evidence both for and against tonic coronary 
vasoconstriction mediated by sympathetic nerves (44). 
Stimulation of parasympathetic centers leads to reflex 
vasodilation (44a). Baroreceptor activity can also affect 
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coronary flow by reducing coronary vascular resistance. 
Adrenergic stimulation and blocade can also modify coronary 
vascular tone. However, these factors are not likely to 
play a major role in the beat-to-beat regulation of coronary 
blood flow and their contribution even under pathological 
conditions is probably a modest one. Several recent reviews 
(42,43,45). deal extensively with this subject. 
-f A 
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4 Autoregulation of Coronary Blood Flow 
Sudden alterations in coronary flow induced by 
extracardiac stimuli are transitory, and the flow quickly 
returns to the baseline level. This mechanism, termed 
autoregulation, tends to maintain coronary flow within a 
relatively narrow range, regardless of changes in the 
perfusion pressures. In fact, it can be demonstrated that 
the CBF remains relatively constant over a wide range of 
blood pressure changes (41,20). Two mechanisms were proposed 
to explain how autoregulation works- myogenic and metabolic. 
Each will be discussed in turn. 
4.1 Myogenic Factors 
It is known that transitory stretch of vascular smooth 
muscle resulting from an increase in perfusion pressure 
stimulates the muscle to contract. This leads to an 
increase in the vascular resistance which in turn leads to a 
decrease in the blood flow through the vessel. Decreased 
perfusion pressure, on the other hand, leads to a 
vasodilation secondary to a reduced smooth muscle stretch. 
In coronary vasculature, reactive hyperemia results in 
blood flow far in excess of the flow deficit incurred during 
the period of occlusion, typically 400 - 600 per cent more 
than the accumulated blood flow debt (46). A close 
examination of this phenomenon revealed that the coronary 
reactive hyperemia includes separate flow and time 
r 
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components. The flow component is due to myogenic 
vasodilation and is approximately equal to the flow deficit 
incurred. The time component is due to the time interval 
required for a washout of different vasodilator metabolites 
(46). Although the myogenic mechanism may contribute to the 
vasodilator response, its role in coronary flow regulation 
is probably a modest one (20). 
4.2 Metabolic Factors 
A number of mediators are effective in the regulation of 
CBF, including lactate, carbon dioxide, P02, K+, H+, 
prostoglandins and adenosine. 
Although hypercapnia can induce vasodilation (47), it is 
unlikely that it plays a major role in the CBF regulation, 
because its vasodilator potential is quite low (48). 
Potassium ions are known to be able to cause coronary 
vasodilation (49). However, potassium release in the 
abscence of ischemia is usually transient and thus it cannot 
account for continuing CBF regulation under normal 
conditions (49). 
Although it was proposed that p02 is directly responsible 
for the control of coronary vascular tone (50), the bulk of 
the available evidence suggests that p02 per se plays little 
or no role in coronary flow regulation (42). 
. I'flOO 
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As could have been expected, prostaglandins were proposed 
as mediators of the CBF regulation. Current evidence 
suggests, however, that prostaglandins play no major role in 
coronary flow regulation (43). 
4.3 Adenosine 
Adenosine's role as a major regulator of coronary flow 
was proposed and vigorously defended by Berne and associates 
(51-57). The adenosine hypothesis states that adenosine, 
produced from intracellular adenine nucleotides is 
continuously released from myocardial cells into 
interstitial fluid, and tha increased MV02 or reduced oxygen 
supply leads to an increased adenosine release (57). 
In order to play this role adenosine must meet the 
following criteria (57): 
1) . It must be a potent coronary vasodilator. 
2) . It must have an endogenous source. 
3) . It should be present under normal physiological conditions. 
4) . Its concentration in the interstitial fluid should be 
sufficient to induce vasodilation. 
5) . There should be a close relationship between adenosine's 
interstitial fluid concentration and coronary flow. 
6) . The time course of adenosine's action should parallel 
the changes in coronary flow. 
7) . Agents that potentiate or attenuate the action of adenosine 
should have a similar effect on endogenously released adenosine. 
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8). A direct cause and effect relationship should be established. 
Although adenosine appears to fullfil most of these 
criteria, almost all aspects of its physiology remain a 
subject of considerable controversy. 
Originally adenosine was proposed as a mediator of 
ischemia-induced vasodilation (51,52). However, later its 
proposed role was extended to include the mediation of 
coronary blood flow in response to increased cardiac 
performance and other non-ischemic stimuli. This aspect of 
adenosine's function is the subject of the most controversy. 
In a large part it is due to the differences in techniques 
used in estimation of adenosine concentration. It is, 
therefore, important to consider in detail the different 
approaches and methods used for this purpose. 
Since it is assumed that adenosine in the interstitial 
flud (ISF*) is responsible for arterial vasodilation, it 
becomes important to measure as accurately as possible ISF 
adenosine concentration. Because there are no ways of 
direct sampling of the ISF adenosine, indirect estimates 
must be used. There are three way to do that: direct tissue 
sampling, coronary sinus- 
arterial blood adenosine concentration difference, and 
pericardial infusate technique. 
Direct tissue sampling was probably the first method 
used for estimation of adenosine concentration. This method 
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is based on the assumption that virtually all existing 
adenosine is produced in the extracellular space by the 
action of an ecto enzyme, membrane-bound 5'-nucleotidase 
(5'-NT). Recent data, however, show that this, perhaps, is 
not the case. First, extrapolation of ISF adenosine 
concentration from the total tissue adenosine content 
grossly overestimates it, for there would be enough 
adenosine even under basal conditions to produce maximal 
vasodilation (58,59). Furthermore, analysis of breakdown 
products of prelabeled adenine nucleotides (58) and of 
adenosine content in the pericardial fluid (59) suggest that 
adenosine to a substantial extent may be localized in the 
intracellualr compartment. Thus, Scharader and Gerlach 
using prelabeled adenine nucleotides found that at least two 
different adenine nucleotide compartments of the heart serve 
as precursors for the formation of adenosine, one 
characterized by high and the other by low specific ativity. 
The fraction with high specific activity appeared to be 
responsible for adenosine production under normal 
conditions, while during ischemia a fraction with low 
specific activity appeared to contribute substantially to 
the total adenosine pool. Both of these fractions appeared 
to be localized intracellularly (58). Olsson et al (59) 
found that treating enzymatically dispersed myocardial cells 
with adenosine deaminase destroyed > 99% of exogenous 
adenosine, but the total tissue adenosine content still 
remained high. This was interpreted by authors to indicate 
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the existence of a large intracellular adenosine pool. 
Schutz et al. (60) studying isolated guinea pig hearts found 
that an intracoronary infusion of a potent 5'-NT inhibitor, 
alpha-beta-methylene adenosine 5-diposphate (AOPCP), which 
inhibited the activity of myocardial ecto-5'-NT by 85%, did 
not influence the release of adenosine provoked by 
accelerated heart rate during hypoxic perfusion. On the 
other hand, intracoronary infusion of nucleoside transport 
inhibitor 4-nitrobenzyl thionosine (NBMPR) resulted in 
decrease of hypoxia-induced adenosine release. 
The presented evidence for intracellular formation of 
adenosine seems rather compelling. However, cytosol is 
known to contain high concentration of adenosine deaminase 
which would immediately degrade any adenosine produced int- 
racellularly. Therefore, one must postulate that 
intracellular adenosine is bound to proteins or some other 
buffer, that prevents its degradation. Whether adenosine 
stored in such a form is readily available for release into 
the extracellular space (a step necessary for coronary flow 
regulation) is completely unknown. Thus, it appears that 
the total tissue adenosine concentration exaggerates ISF 
adenosine content and, at present, cannot be used as a 
relia- ble indicator of it. The subject of intracellular 
adenosine storage and its release clearly requires further 
study. 
The other way of estimation of ISF adenosine 
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concentration involves calculation of coronary sinus- 
arterial blood adenosine concentration difference. As could 
have been expected, there are problems with this method as 
well. Adenosine may be enzymatically degradable in blood, it 
can be taken up by erythrocytes and endothelia cells, and 
the rapidity of its exchange during passage through a 
capillary bed may be insufficient (61). Rubio et al. (62) 
measured the metabolism of adenosine added to the dogs 
blood. They found that 65% was metabolized in 10 seconds. 
In this study, the adenosine metabolism at the end of 10 
seconds was stopped by diluting the blood with ice-cold 
saline, which could have been inadequate for eliminating of 
all enzymatic activity. Olsson et al (63) deproteinized 
blood samples 10 seconds after the addition of adenosine. 
They found that 15-21% of added adenosine was degraded in 10 
seconds. Manfredi and Sparks (64) added dipyridamole, 
ethanol, and EHNA, an inhibitor of adenasine deaminase to 
stop adenosine metabolism in the whole blood. They found 
that about 16% of adenosine is degraded in 10 seconds. 
Klabunde and Althouse (65) using methods similar to Olsson 
et al., found that the mean adenosine half-time was 3.42 
min. with only 3% being metabolized in the first 10 seconds. 
However, adenosine half-life in different dogs in the study 
varied from 1.1 to 7.19 min. Such a wide variation devoids 
the mean value of any physiological significance, and 
indicates that each dog should be assessed separately. 
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Thus it remains uncertain whether the coronary sinus - 
arterial blood adenosine concentration difference accurately 
reflects the ISF adenosine concentration, because of 
possibly substantial adenosine metabolism by the whole blood 
and wide differences in this enzymatic ability between 
different animals. Anyone attempting to estimate ISF 
adenosine concentration using this method should probably 
estimate each dog's enzymatic capability for adenosine 
degradation individually. 
The last method used for estimation of ISF adenosine 
concentration is a pericardial infusate technique developed 
by Berne's group. The method involves infusing 40 cc of 
modified Krebs-Henseleit solution which is withdrawn 4.5 
minutes later. Adenosine concentration is then determined in 
this infusate. This technique has its own share of problems 
as well. First, adenosine in the pericardial infusate 
arises exclusively from the epicardium, and thus may not 
reflect ISF adenosine concentration in the deeper myocardial 
layers, especially in the subendocardium. This may not be a 
problem since it has been shown that under normal conditions 
(66) and during aortic constriction (67) adenosine is 
distributed uniformlyy through the myocardial wall. However, 
it is quite possible that different interventions may affect 
the transmyocardial adenosine distribution, thus rendering 
pericardial infusate adenosine concentration an inaccurate 
estimate of the ISF adenosine concentration in the deep 
myocardial layers. The other problem with the technique is 
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that endogenous pericardial adenosine content does not 
attain equilibrium with estimated ISF levels (68). 
Furthermore, pericardial infusate adenosine concentration 
can be altered by adenosine uptake. Therefore, pericardial 
infusate adenosine can be a reliable estimate of ISF 
adenosine only under steady-state conditions. 
It is, thus, clear that none of the techniques used for 
assessement of the ISF adenosine concentration is perfect 
and the limitations of each should be kept in mind when 
different studies are compared. 
4.4 Adenosine production with increased cardiac 
performance 
Although it has been shown many times that adenosine release 
under ischemic conditions parallels the change in coronary 
flow, it is important to demonstrate that coronary flow 
changes induced by conditions other than ischemia are also 
mediated by adenosine. 
Weidmeir and Spell (69) studied effects of changes in 
myocardial oxygen demand (MV02) and contractility on 
myocardial adenosine production and coronary flow in 
isolated guinea pig hearts. They found that catecholamines 
increased riV02 and contractility, while adenosine 
concentration in the coronary sinus blood increased 
proportionally to the degree of increase in coronary flow. 
Nitroglycerine, on the other hand, increased contractility 
but did not change MV02. No change of adenosine 
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concentration was detected. 
Miller et al. (68) studied the effects of stellate 
ganglion stimulation on MV02, coronary flow and adenosine 
production using pericardial infusate technique. They found 
that ganglion stimulation resulted in the increase in MV02, 
pericardial infusate adenosine and coronary flow to the same 
extent. 
Watkinson et al. (70) using pericardial infusate 
technique demonstrated increased adenosine production with 
stellate ganglion stimulation as well as with treadmill 
exercise. In these experiments, dos were fitted with a tube 
connected to the pericardial sac. Adenosine levels were 
measured before, during, and after the treadmill exercise. 
No difference was found between adenosine levels before and 
after the exercise, but a 2- to 3-fold increase in the 
infusate's adenosine concentration was noted during the 
exercise. 
Later, McKenzie et al (67) demonstrated that after 10 
minutes of treadmill exercise at 5 mph, there was a 2-fold 
increase in coronary flow and MV02 associated with a 3-fold 
increase in the myocardial adenosine levels. 
Saito et al (71) used tissue sampling technique to 
evaluate changes in adenosine concentration induced by 
pacing, aortic constriction, or beta-blockade. In all cases, 
adenosine concentration varied directly with changes in 
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MV02, while coronary resistance varied inversely with 
changes in adenosine's concentration. 
Manfredi et al. (64) also studied changes in adenosine 
concentration, using coronary sinus- arterial blood 
concentration difference multiplied by coronary plasma flow, 
MV02 and coronary resistance during atrial pacing and 
norepinephrine infusion. They found that during 
norepinephrine infusion adenosine concentration rose 
proportionally to the fall in coronary resistance, while 
MV02 also rose. But during atrial passing there was 
observed no change in adenosine concentration as MV02 rose 
and coronary resistance fell. 
Bacchus et al. (61) studied changes in coronary flow and 
adenosine concentration by pericardioal infusate method in 
chronic dog during treadmill exercise, feeding, and exposure 
to loud noises. They found a significant increase in adeno¬ 
sine's concentration with all interventions, and a 
significant correlation between MV02, coronary flow and 
changes in adenosine concentration. 
Thus, a variety of studies seem to indicate that 
adenosine may be a mediator of coronary flow changes during 
increased myocardial performance, as caused by treadmill 
exercise, norepinephrine stimulation, feeding, excitement 
due to loud noises or stellate ganglion stimulation. 
Effects of tachycardia are less clear with one group (71) 
claming that induced changes in coronary flow are adenosine- 
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mediated, while another group (64) found no association 
between changes in adenosine's concentration and flow. The 
difference is most likely related to the differences in 
techniques and further studies are needed to settle this 
matter. 
Another way of altering coronary blood flow, in addition 
to ischemia and increased cardiac performance, is 
nonischemic hypoxia. HF Downey et al. (72) studied the 
effects of nonischemic hypoxia on coronary flow by 
selectively perfusing the left anterior descending artery 
with hypoxic blood (P02 11.7 torr). They observed a 600% 
rise in coronary flow, similar in magnitude to the rise in 
flow observed with ischemic hypoxia (coronary artery 
occlusion). ISF adenosine concentrations were measured by 
myocardial sampling technique. It was found that the ISF 
adenosine concentration was actually reduced while coronary 
flow surged. However, assessement of the ISF adenosine 
concentration by direct tissue sampling under conditions of 
nonischemic hypoxia may be especially inaccurate. Indeed, 
adenosine's metabolism or release has not been studied under 
such conditions and it is qute possible for ISF adenosine to 
increase while the total tissue adenosine concentratio is 
decreased. Furthermore, nonischemic hypoxia is a rather 
nonphysiologic stimulus, especially as severe a one as was 
used by Downey et al. (72). Therefore, it is quite possible 
that coronary flow changes induced in such a way are not 
mediated by adenosine but rather directly by oxygen. 
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As is well known, myocardial MV02 is greater during 
systole than diatole. In a way, we have a physiologic model 
of increased cardiac performance during a specific part of 
the cardiac cycle (systole). Thus, one of the greatest 
challenges for adenosine hypothesis is to prove that the ISF 
adenosine concentration can change fast enough to accomodate 
changing myocardial needs during systole. The answer to 
this question was given in an elegant study by Thompson et 
al (73). They studied systolic and diastolic myocardial 
concentrations of adenosine and its degradative products, 
inosine and hypoxanthine, in isolated perfused guinea pig 
hearts. The heart rate was slowed down and the systole and 
diastole were prolonged by 186% and 907% respectively by 
crushing the sinus node and substituting Sr for Ca in the 
perfusate. The authors found a significant increase in 
adenosine and its degradative products during systole as 
compared to diastole. The addition of EHNA, an adenosine 
diaminase blocker, resulted in a significantly higher 
systolic than diastolic adenosine concentration. 
To summarise, we have an impressive array of evidence 
implicating adenosine as the principal mediator of coronary 
blood flow during physiologic conditions as well as during 
conditions of ischemia or increased myocardial performance. 
Furthermore, it was shown that adenosine concentration can 
change fast enough to accomodate changing myocardial needs 
during a single cardiac cycle. Thus, although not all of 
the criteria set forth by Berne are as yet met by adenosine 
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it appears increasingly clear that it will prove to be the 
mediator of coronary blood flow. 
4.5 Adenosine metabolism 
Some of the aspects of adenosine's metabolism have 
already been discussed in the section on direct tissue 
sampling. It was originally assumed that AMP formed as a 
result of ATP hydrolysis (ATP - ADP - AMP) serves a 
substrate for 5'- NT, an ecto enzyme, and that almost all 
adenosine is formed extracellularly (57,74). As has already 
been mentioned, analysis of breakdown products of prelabeled 
nucleotide precursors suggests that adenosine may, to a 
substantial extent, be produced and localised 
intracellularly (58,59). Schutz et al. (60) found that 5'- 
NT inhibitor did not markedly reduce the rate of ischemia- 
induced adenosine production, while infusion of nucleoside 
transport inhibitor significantly decreased adenosine 
production. Furthermore, it was found that appreciable 
quantities of 5'- NT are located in a 200,000- g cytosol 
fraction (60). 
Olsson et al. (75) suggested that AMP used as a substrate 
for adenosine production is generated from cAMP by the 
action of phosphodiesterase, rather than from hydrolisis of 
ATP. The size of adenosine pool would therefore be 
dependent on the concentration of cAMP and factors that 
affect it. There is, unfortunately. no hard data to 
determine whether adenosine is produced via cAMP or ATP 
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hydrolysis pathway. 
Recently, a new possible source of adenosine in the heart 
has been described. Schutz et al. (60) found that there was 
a high specific activity of S- adenosylhomocysteine (SAH) 
hydrolase present in the guinea pig hearts. The enzyme was 
present exclusively in the cytosol and exhibited a low Km. 
It catalysis the followong reaction: 
SAH = Adenosine + L- homocysteine 
Although the equillibrium constant of this reaction favors 
synthesis of SAH, under conditions prevailing in the 
myocardium it may not be so. 
Adenosine concentration in the interstitial fluid depends 
on the relative rates of its production, reuptake by 
myocytes, washout and conversion to inosine and hypoxanthine 
by adenosine deaminase (46). Conversion to inosine and 
hypoxanthine appears to be the predominant mechanism. Thus, 
the following scheme of adenosine metabolism can be 
proposed: 
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Inosine 
It remains to be determined whether AMP used in adenosine 
production is formed from cAMP or ATP hydrolysis, and what 
role does SAH play in adenosine metabolism. Furthermore, it 
is necessary to determine how intracellularly formed 
adenosine is protected from degradation by adenosine 
deaminase, a ubiquitous cytosol enzyme. Also, adenosine 
transport across the plasma membrane and stimuli for its 
release need to be studied. 
4.6 Mechanism of action 
The molecular mechanism of adenosine's action is not well 
understood. There exist several possibile mechanisms. One 
possibility is that adenosine acts via production of an 
increased smooth muscle cAMP concentration. Increase in 
CAMP concentration has been shown to be associated with 
vascular smooth muscle relaxation (76). Furthermore, 
adenosine has been shown to increase cAMP content in the 
brain (77). However, Herley et al. (78) found that only 
pharmacological doses of adenosine resulted in significant 
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increase in cAMP levels in hog carotid artery strips. 
Several other investigators also reported essentially 
similar results (79). 
A second possibility is that adenosine acts by inibiting 
calcium transport in smooth muscle cells or interferes with 
calcium utilization in the contractile machinery of these 
cells (57). Adenosine was shown to decrease the force of 
contraction, uptake of Ca++ and the plateau phase and 
duration of action potential in atrial muscle in guinea pig 
(80). 
A third possibility is direct adenosine induced 
relaxation of vascular smooth muscle. Thereis a strong 
evidence for existence of a specific adenosine receptor on 
cardiac muscle, coronary arteries and carotid arteries in 
the dog and rabbit (79). It is unknown at present whether 
adenosine acts via one or a combination of these mechanisms. 
It does seem clear that the vasodilator action of adenosine 
is initiated by the attachment to the coronary myocyte's 
adenosine receptor (57). 
Schrader et al. (81) synthesized large molecular weight 
protein- AMP conjugate that was confined to the extacellular 
space. When infused into coronary arteries of isolated 
guinea pig hearts, it induced vasodilation similar in 
magnitude and time course to vasodilation elicited by 
adenosine or AMP. It was concluded that since the observed 
vasodilation was most likely induced by adenosine moiety of 
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AMP, there exists a surface receptor for adenosine and/or 
AMP. 
Lee et al. (82) studying binding of a specific adenosine 
receptor agonist, phenylisopropyladenosine, to an enriched 
cardiac sarcolemma preparation found that the specific 
binding was rapid and saturable. Computer analysis revealed 
a single class of binding sites. Schocken et al. (83) used 
labeled adenosine to assess its binding to the ventricular 
myocardium. They found that competetive binding for labelled 
adenosine was saturable, of high capacity, with extremely 
rapid reversability, and high affinity. Furthermore, 
adenosine-induced dilatation of the coronary vessels is not 
affected by adrenergic blocking agents, indicating that the 
adenosine receptor is separate from adrenergic receptors 
(57). 
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5 Transmyocardial Distribution of Coronary Blood Flow 
The studies of transmyocardial distribution of coronary 
blood flow effectively began with the work of Kirk and Honig 
(33). They studied the blood flow distribution and oxygen 
tension in normal canine hearts by depot-clearing method. 
These studies involve injecting 1131-labeled sodium iodide 
into the myocardium at varying depths and estimating 
clearance of the isotope over time. The obtained data 
indicated at least 25 per cent slower blood flow in deep 
(subendocardial) layers than in superficial regions. Using 
Xel33 washout studies, Brandi et al. (84) also found 
relative hypoperfusion of subendocardial layers under basal 
conditions. On the basis of these and several other studies 
also employing the depotclearing method (33,84,85), it was 
suggested that anaerobic metabolism may take place in the 
subendocardium (33), or that subendocardial layers might be 
perfused directly from the LV cavity via lumenal channels 
(86). 
Further support of these hypotheses came from studies 
indicating that relatively higher levels of glycogen, 
phosphorylase activity (87), and other glycolitic enzymes 
(88,89) exist in the subendocardium. Allison and Holsinger 
(90) found significant transmural gradients of high energy 
phosphate compounds and lactate, which they interpreted as 
evidence of reduced oxydative and increased glycolytic 
reserve in the endocardium. Based on these findings, a model 
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of transmural flow regulation was proposed. This model 
postulates that endocardial vessels are maximally dilated in 
order to provide nutrition to the endocardium, which is 
nearly ischemic even under basal conditions. The endocardium 
is also relying on anaerobic metabolism to meet its energy 
requirements (91). 
The hypothesis that subendocardial layers are supplied 
from the LV cavity via lumenal channels was soon shown to be 
incorrect (92). There is also an impressive array of 
evidence against predominantly anaerobic metabolism in the 
subendocardium (89-91). 
Further advances in the field occurred with the 
development of microsphere flow studies. It was conclusively 
demonstrated that the transmural distribution of 9 micron 
microspheres closely approximates blood flow (94,95), and 
that of 15 micron microspheres also quite accurately 
reflects the flow (96). Microsphere blood flow distribution 
studies soon demonstrated that there was no underperfusion 
of the subendocardium under basal conditions, and that in 
some cases subendocardial flow even exceeded subepicardial 
flow (97-99). Previous studies utilizing depot-clearing 
technique of flow determination were further criticised on 
the ground that local conditions created by isotope 
injections (local edema, hemorrhage, local vasomotion and 
leakage of the injectate up the needle tract) distort the 
flow data (100). It is, therefore, considered established 
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that subendocardium is not underperfused under normal 
conditions and that, indeed, transmyocardial flow is 
distributed equally through the LV wall. 
One, thus, needs to account for this equality in 
distribution, especially considering the much greater 
systolic extravascular resistance in the subendocardium. As 
it has been aluded to previuosly, when coronary flow is 
restricted to systole, the epicardial flow greartly exceeds 
the endocardial flow. This difference is directly 
attributable to the systolic transmyocardial pressure 
gradiet (101). As has been discussed in the section on 
extravascular resistnce, coronary vessels compression by the 
contracting myocardium is the predominant factor determining 
the magnitude of the systolic extravascular resistance, 
while systolic strains play only a minor role. To expain 
the uniformity of transmyocardial flow, it is necessary 
first to discuss the factors regulating transmural flow 
distribution in systole and in distole. 
5.1 Systolic transmural flow distribution 
To explain the predominant perfusion of subepicardial 
over subendocardial areas when the flow is confined to 
systole, Downey and Kirk (102) proposed a model explaining 
this gradient. The proposed model, called vascular 
waterfall model, is based on assumptions somewhat different 
from the conventional flow dynamics. The classic 
description is given by Poiseuille's law 
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Q = (Pi - Po) X 1/R 
where Pi is inflow, Po outflow pressures and R is 
resistance. If, however, we have a collapsible vessel 
surrounded by a higher pressure medium, the situation 
changes. Now, if the extravascular pressure (Pc) exceeds the 
outflow pressure, the flow is determined by the 
extravascular pressure. The flow equation, therefore, 
changes as follows: 
Q = (Pi - Pc) X 1/R 
A peculiarity of this system is that a change in flow has no 
influence on the pressure drop across the end of the tube, 
and a change in the pressure drop across the end of the tube 
has no influence on flow (103). Resistance in such a system 
is determined by the interaction of Pi and Pc. More 
specifically, it is determined by the degree of vessel 
constriction created by these two opposing pressures. When 
the constriction created by the partial vessel collapse 
generated by Pc results in sufficint luminal pressure to 
prevent further vessel narrowing, an equilibrium will be 
reached. The cross- sectional area of the orifice 
(narrowing) created by the vessel constriction will, 
therefore, determine the flow through the whole system. 
This can be described by the following equation: 
Q = A 2 X (Pc - Pi) X 1/d 
where A is cross- sectional area of the orifice and d is 
density of flow (103). In Downey and Kirks's model coronary 
circulation consists of numerous parallel channels, each 
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responding to the local tissue pressure by forming vascular 
waterfalls. Therefore, higher intramyocardial systolic 
pressure in subendocardial layers will result in formation 
of vascular waterfalls there with resulting decrease in 
subendocardial flow. 
It should be noted that the waterfall model can only be 
applied to systems with very low Reynold's numbers, i.e. < 1 
(104). Blood flows characterized by such low Reynold's 
numbers occur only in the microcirculation and it is not 
entirely clear if the waterfall model can be accurately 
applied to the coronary circulation. However, the resulting 
error, if an, is likely to be rather small. 
5.2 Diastolic transmural flow distribution 
Thus, it is well established that during systole 
epicardial flow greatly exceeds endocardial. And yet, the 
endo/epi flow ratio remains near unity. It follows 
therefore, that diastole largely favors flow in the 
subendocardium. The mechanism(s) for this preferential 
diastolic endocardial flow is unclear. 
To account for the equality in the transmural flow 
distribution, one has to postulate a lower diastolic 
vascular resistance in the subendocardium than in the 
subepicardium. Diastolic vascular resistance is determined 
by the extravascular resistance (diastolic intramyocardial 
pressure), intravascular resistance (coronary artery tone) 
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and the gradient of vascularity. 
The subject of the diastolic intramyocardial pressures 
has been discussed at length in the section on extravascular 
resistance. There exist conflicting results regarding the 
existence, direction, and magnitude of the diastolic 
pressure gradient. But even if one assumes higher 
intramyocardial pressures in the subepicardium than in the 
subendocardium, the magnitude of pressures themselves is 
probably not sufficient to account for a much higher 
diastolic endocardial flow. Thus, while during systole, 
extravascular resistance plays a dominant role in the 
transmural flow distribution, during diastole its role is a 
minor one. 
The concept of the gradient of vascularity implies 
anatomically determined higher vessel density in the 
endocardium rather than the epicardium. While there are 
very little direct anatomical data supporting this 
hypothesis, some phsiological data appear to be consistent 
with it. 
Downey HF et al (105) studied transmyocardial flow 
distribution in fibrillating hearts with pharmacologically 
induced maximal vasodilation. They found that under such 
conditions endo/epi flow ratio was 1.37. This can be 
interpreted to indicate that the endocardial vascular 
resistance is 30-40% lower than the epicardial. Downey JM 
and Kirk (106) studying transmocardial flow distribution in 
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arrested hearts with maximally dilated coronary arteries 
found that the endocardial resistance was 20% lower than the 
epicardial. Wusten et al (107) also found that the 
endocardial vascular resistance is lower than the 
epicardial. It appears, therefore, that indeed vascular 
density is higher in the subendocardium than in the 
subepicardium. 
If we assume that at normal heart rates diastole is about 
3 times longer than systole, then 30% difference in 
resistance due to the gradient of vascularity, aided perhaps 
by the intramyocardial pressure gradient, would be just 
enough to equalize the total flow distribution. It is 
clear, however, that, for example, tachycardia which results 
in the relative shortening of diastole, would result in 
endocardial underperfusion if no other mechanism were 
opertional. Studies performed on chronically instrumented 
awake dogs demonstrated that when maximal vasodilation was 
achieved with adenosine, increse in the heart rate resulted 
in the fall of the endo/epi flow ratio (108). When adenosine 
was not administered, endo/epi ratio remained constant 
despite the increase in the heart rate from 100 to 250 
beats/min. Therefore, some active vasomotion is required to 
maintain the uniformity of transmyocardial blood flow during 
tachycardia as well as during other stresses on the heart. 
A variety of metabolic factors such as K+, lactate, C02, 
ATP/ADP can conceivably accumulate in the endocardium and be 
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responsible fr this vasomotion. In most studies, however, 
there were found no differences in the concentrtion of these 
metabolites between the epicrdium and the endocardium. 
(109,110,91). Perhaps, adenosine, which plays a major role 
in coronary flow regulation, can be responsible for 
maintaining the equality of transmural perfusion? Studies 
on transmural adenosine concentration showed no significant 
difference between the epicardium and the endocardium under 
normal conditions (66) or during aortic stenosis (67). 
Coronary artery stenosis, however, resulted in higher 
endocardial than epicardial adenosine concentration (66). 
But this degree of coronary artry stenosis (50%) is known to 
produce transmyocardial lactate gradient which indicates the 
occurence of subendocardial ischemia (91) and, thus, cannot 
be considered a fair test of adenosine's role. 
No data are available regarding the transmural adenosine 
concentration during tachycardia or other states of 
increased cardiac performance. It may not be necessary, 
however, to have a higher endocardial adenosine 
concentration in order to obtain a necessary degree of 
coronary subendocardial vasomotion. The other possibility 
is that endocardial vessels may be more sensitive to adeno¬ 
sine than epicardial, or, perhaps, a threshold for adenosine 
induced vasodilation is lower in the subendocardium than the 
subepicardium. 
Rembert et al.(lll) found that submaximal doses of 
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adenosine resulted in the increased endo/epi flow ratio, 
wich could not be explained by the difference in P02, since 
even when P02 was unphysiologically high, the increased 
endo/epi flow ratio still persisted. There were, however, 
significant differences in the heart rate, and systolic and 
diastolic blood pressures between the control, maximal 
vasodilation, and and submaximal vasodilation groups, all of 
wich could influence the transmyocardial flow distribution. 
On the other hand Warltier et al. (112) using isolated 
canine hearts found that intracoronary infusuion of 
adenosine produced a dose- dependent shift in transmural 
coronary flow away from the subendocardium. 
To further investigate the role of adenosine in the 
transmyocardil flow distribution and the question of higher 
endocrdial vessel sensitivity to adenosine, we studied 
coronary flow changes under conditions of varying adenosine 
concentration. Obtained results (113) indicate that, 
indeed, in the absence of heart rate, blood pressure, and 
left atrial pressure variations, submaximal doses of 
adenosine increse preferentially subendocardial blood flow, 
resulting in the increased endo/epi flow ratio. 
Maximal vasodilation induced by adenosine in the beating 
hearts has been shown on many occasions to result in 
decreased endo/epi flow ratio. This is not surprising, 
considering that large doses of adenosine administered to 
achieve this maximal vasodilation virtually eliminate any 
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subendocardial vasomotion. Then, the sytolic extracoronary 
resistance becomes the only remaining factor influencing the 
flow distribution. 
On the basis of the described studies, the following 
model of the transmural flow regulation can be proposed. 
During systole vascular waterfalls are created which result 
in significantly lower flow to the subendocardial than 
subepicardial areas. During diastole several factors 
contribute to maintence of the adequate perfusion. First, 
the gradient of vascularity favoring the endocardium exists 
in the myocardial wall. This gradient is of sufficient 
magnitude to assure adequate endocardial flow at normal 
heart rates and MV02. Endocardial vessels are more sensitive 
to adenosine than epicardial vessels, and this adenosine- 
induced vasomotion accounts for the uniform transmural flow 
distribution during tachycardia or states with increased 
myocardial performance. 
Obviously, further studies are needed to substantiate 
this model. Thus direct tests of coronary arteries from the 
endocardial and epicardial areas can give additional 
information regarding the differences in adenosine 
sensitivity. It has been shown that adenosine concentration 
can change fast enough to accomodate for the difference in 
MV02 between systole and diastole (73). It is, however, 
unknown if its concentration can change fast enough at rapid 
heart rates. Finally, the prescise nature of transmyocardial 
- 
47 
diastolic pressure gradient and its contribution to 
diastolic extravascular resistance should be elucidated. 
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CHAPTER TWO 
CATECHOLAMINE CARDIOMYOPATHY 
1 Introduction 
Catecholamines given in high concentrations produce 
considerable myocardial damage. This has been demonstrated 
experimentally in several mammalian species (114-116). 
Similar changes have been found in patients dying of shock 
who were given large amounts of catecholamines (117,118) and 
in patients with pheochromocytomas (117, 119-121). 
The histopathological changes induced by catecholamines 
include myofiber necrosis, myofibrillar degeneration and 
leukocytic infiltration (114-116). The lesions are usually 
more prominent in the subendocardial areas. It has been 
demonstrated that the severity of the injury is a function 
of both the dose and duration of norepinephrine (ME) 
infusion (116,122). A reproducible model of NE 
cardiomyopathy in rabbits has been developed by Downing and 
Lee (116). They showed that a short-term (90 minute) 
infusion of NE in relatively modest doses (2-3 g/kg/min) 
leads to a consistent pattern of myocardial injury, readily 
identifiable by light microscopy as well as by radionuclide 
cardiac imaging (116,123). 
Studies of cardiac function utilizing either afterload 
curves (124) or standard VF curves (125) revealed 
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significant impairment of LV performance. Thus, it has been 
conclusively established that administration of NE leads to 
substantial myocardial injury associated with reduced LV 
performance. The pathogenesis of this cardiomyopathy has, 
not been clearly established, however. 
It has been shown recently that while beta-blockers do 
not prevent NE-induced damage, alpha-antagonists such as 
phentolamine can effectively prevent the 1 on (126). 
Furthermore, administration of a pure alpha-agonist such as 
methoxamine, results in essentially identical lesions, and 
the severity of these lesions depends on the dose of 
methoxamine given (126). This suggests the possibility that 
the mechanism of lesion production in the norepinephrine 
cardiomyopathy involves coronary vasoconstriction through 
alpha-adrenergic pathways, sufficient to cause injury to the 
myocardium. The present study was undertaken to test this 
hypothesis. 
. .n.'= 
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2 Pathology 
The cardiotoxic properties of catecholamines have been 
known for a considerable length of time. Pearce in 1906 was 
one of the first to describe myofibrillar edema, loss of 
striation and increase in fibrous tissue in the heart after 
several injections of adrenaline (124). Soon thereafter, it 
was shown that norepinephrine can also induce a 
cardiomyopathy (125). Since than, cathecholamine 
cardiomyopathy has been demonstrated to occur in several 
species of laboratory animals, including rabbits, dogs and 
cats (114-116). It has also been reported to occur in 
people treated with large doses of catecholamines as well as 
in patients with pheochromocytomas (117, 119-121). 
Morphologically, the lesions of catecholamine 
cardiomyopathy are similar in all species examined, 
including man, and do not vary with the catecholamine used. 
The severity of the injury depends on the dose and duration 
of administration. The gross and microscopic appearance of 
the lesions depends on the time elapsed between the dose 
administration and the sacrifice of the animal. 
Early changes include subendocardial congestion and 
hemorrhage (118,122,128,129). Occasionally, edema and 
hemorrhages into the valve leaflets are also present (128). 
On microscopic examination, vascular congestion, 
interstitial edema and focal myofiber degeneration with loss 
of individual myofiber striation are observed (118,128,130). 
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Vacuolization and accumulation of the lipid material in the 
myocardial cells are also commonly seen (118,130). The 
first changes to be detected under electronmicroscopic 
examination, minutes after catecholamine infusion, are areas 
of hypercontracted myofibrills with wide Z lines and 
"contraction bands" (130,131). Tearing of myofilaments away 
from sarcomeres has also been noted (131). Other 
observations include reduced numbers of glycogen granules 
and dilatation of the transverse tubules (130,132). 
Within several hours myocardium appear stiffened and less 
pliable (133). Microscopically, interstiatial edema with 
polymorphonueclear cell infiltration is observed. 
Electronmicroscopically, the number and extent of 
"contraction bands" increases and the sarcomeres begin to 
show loss of architecture (114,131). Somewhat later, 
mononuclear cells appear and gradually come to predominate 
in the lesions. Perivascular Anitschkow myocyte type cells 
are also observed. Fibrinoid degeneration of arterioles has 
also been noted (118,122). 
Two to five days later, areas of fibrosis can be observed 
on gross examination. Microscopically, foci of necrosis 
with dissolution of myofibers and infiltration of 
mononuclear cells are seen. At this time also, scarring 
appears in the interstitium. Depending on the dose and 
duration of drug administration, the lesions are either 
transmural or subendocardial. But even with transmural 
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injury, subendocardial layers are affected to a greater 
extent than are subepicardial layers. Over the next several 
weeks, the acute inflammatory changes subside and fibrous 
replacement of the destroyed myocardium occurs. 
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3 Pathophysiology 
The catecholamines produce a rather specific 
morphological pattern of injury. However, it is important 
to determine if this damage has physiological consequences 
such that the functional capacity of the heart is reduced. 
Werner et al. (124) using a rabbit model of ME induced 
cardiomyopathy studied the effects of changes in afterload 
on ventricular function. They found that in cardiomyopathic 
rabbits pressure-function curves were lower than in control 
animals, indicating reduced LV performance. 
Myocardial contractility in animals with catecholamine 
cardiomyopathy was studied by Fripp et al. (134) They found 
that resting dP/dt max did not differ from control animals, 
suggesting no difference in the resting contractile state. 
However, proportional increases in dP/dt max during ME 
administration were sharply lower in cardiomyopathic than 
in control animals. Because the cardiomyopathic animals 
exhibited some evidence of left ventricular failure, as 
manifested by increased LVEDP, a reduction in 
intramyocardial ME stores and increased sensitivity to 
exogenous NE would be expected. Since ME infusion studies 
demonstrated decreased sensitivity of the myocardium to 
exogenous NE administration, changes in contractility in 
this case are probably not related to altered myocardial NE 
stores. When contractility was assessed during infusion of 
Ca++, it was also found that the rise of dP/dt max in 
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cardiomyopathic group was much smaller than in control 
animals. This suggests some abnormality in the contractile 
apparatus itself, possibly in excitation-contraction 
coupling (134). Since the response to Ca++ was also 
diminished, the beta-receptor system was probably not 
involved. 
The studies discussed above have demonstrated that 
catecholamine cardiomyopathy results in decreased capacity 
to respond to afterload stress (124), and reduced inotropic 
responses to NE and Ca++ administration. The latter finding 
indicate reduced ability to augment contractility (134). It 
is well known, however, that changes in contractility may 
dissociate from changes in the pump function in several 
pathophysiological states (135,136). Hence, it is important 
to directly examine pump function in catecolamine 
cardiomyopathy. 
Studies of left ventricular function using changes in 
preload demonstrated a significant reduction of the pump 
function. Mean stroke volume at LVEDP of 10 cm H20 (SVIO) 
was 1.16 ml in the control group and .93 ml in the 
cardiomyopathic animals, a 20% reduction (125). On the 
other hand, the ability of the cardiomyopathic hearts to 
augment the global pump function was the same as that of 
control animals as demonstrated by a comparable percent 
increase in SVIO during catecholamine administration (125). 
Thus catecholamine cardiomyopathy is yet another state (in 
'i H. J 
55 
addition to circulatory shock and myocardial infarction), 
where there exists a dissociation between the global pump 
function and contractility. 
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4 Pathogenesis 
A number of theories have been advanced to explain the 
mechanism of catecholamine induced damage. As has been 
noted, one of the earliest morphological features is 
subendocardial hemorrhage. Since vagal stimulation has also 
been shown to result in subendocardial hemorrhages, and 
since catecholamine administration results in increased 
vagal discharge, Szakacs (117) suggested that provoked vagal 
discharge is at least partially responsible for the observed 
injury. 
Catecholamine induced alterations in lipid metabolism has 
been proposed as another possible mechanism. Hoak (130) 
noted that catecholamines stimulate mobilization of lipids 
from the adipose tissue stores, producing increased levels 
of serum free fatty acids (FFA). This could result in 
increased myocardial FFA concentration with uncoupling of 
oxidative phosphorylation and direct myocardial tissue 
damage. There are, however, a number of problems with this 
hypothesis. First, it is known that the lesions of 
catecholamine cardiomyopathy predominate in the 
subendocardium (118,122). It is not clear how the lipid 
hypothesis would account for such a distribution. Secondly, 
myocardium possesses very efficient means for matabolizing 
free fatty acids. Furthermore, it remains to be 
demonstrated that increased plasma levels of FFA result in 
increased myocardial FFA concentrations or that increased 
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myocardial FFA content results in myocardial damage. 
Haft and colleagues proposed that occlusion of small 
cardiac vessels by platelet aggregates is the dominant 
mechanism of damage in catecholamine cardiomyopathy 
(137-139). When dogs were pretreated with aspirin or 
dipyridamole prior to epinephrine infusion, the extent of 
injury was significantly reduced (137). Electronmicroscopic 
studies immediately after a 4-hr infusion of NE demonstrated 
platelet aggregates in the small vessels (138). It was 
postulated that platelet thrombi play a significant role in 
catecholamine injury (139). However, other investigators 
have been unable to confirm the presence of platelet 
aggregates after catecholamine administration (121,126). 
Platelet microthrombi hypothesis also does not explain the 
subendocardial predominance of the lesions. While it is not 
clear why pretreatment with dipyridamole or aspirin resulted 
in decreased injury it is unlikely that platelet aggregates 
play a substantial role in the development of catecholamine- 
induced damage. 
As early as 1909 Fleisher and Loeb suggested that violent 
contractions caused by adrenaline may result in myocardial 
damage (133). Nahas (129) studying myocardial effects of 
catecholamines in an isolated heart-lung preparation, 
suggested that a prolonged myocardial tension may be 
responsible for the lesion production. Csapo et al. (131) 
studying early electronmicroscopic changes after 
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isoproterinol administration found that the first observed 
changes were related to hypercontraction of myofilaments 
with formation of contraction bands and disorganized and 
fragmented myofibrills. 
Pretreatment with insulin sharply reduces the inotropic 
response of the muscle to NE in the isolated heart (140). 
When insulin is administered to intact animals before NE 
infusion, the extent of the damage is substantially reduced 
(116). These data support a mechanical injury hypothesis, 
indicating that reduced inotropic responsiveness after 
pretreatment with insulin reduces catecholamine induced 
damage. 
NE is known to increase intracellular cAMP and NaH- 
concentrations (141,142). Increased intracellular Na+ 
levels lead to increases in intracellular Ca++ 
concentrations. This could result either from increased 
Na/Ca exchange or from release of Ca++ from intracellular 
stores (143,144). It is well known that elevated 
intracellular Ca++ concentrations increase inotropic state 
due to Ca-mediated inactivation of troponin-tropomyosin 
system and enhanced actin-myosin interaction. Excessive 
intracellular Ca++ concentrations could conceivably lead to 
irreversible hypercontraction (116), consistent with the 
morphological changes described by Csapo et al. (131). It 
is not clear how insulin prevents the catechol induced 
damage. Possibly, it limits Na+ influx into the cells by 
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blocking an insulin-sensitive Na+ pump (145). However, a 
direct, steroid-like membrane stabilizing effect cannot be 
excluded (116) . 
Myocardial tension development is greatest in the 
subendocardium. Thus myocardium in this region would be 
expected to be undergo more systolic stretch than in the 
subepicardium, resulting in increased diastolic sarcomere 
length. Since it appears that the sarcomere sensitivity to 
calcium is lengthdependent (146,147), subendocardial 
myocardium would be more sensitive to changes in the 
intracellular Ca++ concentration. Hence, most of the damage 
would be expected to occur in the subendocardial area, as 
indeed is observed morphologically. 
Ischemia is another potential mechanism by which 
catecholamine damage can be induced. It can result from the 
vasoconstriction with reduced oxygen supply, or from the 
increased myocardial oxygen demand disproportionate to 
changes in coronary flow. As early as 1906, Pearce (127) 
suggested that adrenalin induced vasoconstriction is 
responsible for the observed injury. Handforth (148) 
infused india ink into the coronary arteries of hamsters 
sacrificed shortly after isoproterinol infusion and found 
reduced flow to the subendocardial areas of the left 
ventricle. He concluded that muscle injury was due to the 
ischemic infarction. Using electronmicroscopic techniques, 
Ferrans et al. (114) also concluded that isoproterinol 
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injury is ischemic in nature. Schenk and Moss (122) 
studying ME induced damage concurred that ischemia is a 
major mechanism of injury and suggested that a fall in blood 
pressure observed shortly after the onset of infusion 
further compromises coronary flow by reducing the perfusion 
pressure. Because of high systolic tension, subendocardial 
02 usage is greater than in the rest of the myocardium. At 
the same time, subendocardial vascular reserve is less than 
subepicardial. A combination of these factors makes 
subendocardium particularly sensitive to reductions in 
coronary blood flow. Thus any agent inducing myocardial 
damage by altering coronary flow would be expected to have 
its greatest impact on the subendocardium, as indeed is 
observed in catecholamine cardiomyopathy. 
Since norepinephrine possesses both alpha and beta 
adrenergic properties, both pathways may be involved in 
production of the lesions. Although beta-receptors are 
clearly the dominant receptors in cardiac tissue ( 149,150), 
a recent study failed to show any protective effect of beta- 
blockade with large doses of either propranolol or proctolol 
on NE-induced damage (126). While this does not rule out a 
role for beta-receptors in mediating the damage, it is 
clearly not the predominant pathway. On the contrary, alpha 
blockade with phentolamine sharply reduces the extent of ME 
damage (126). Furthermore, lesions can be induced by a pure 
alpha-agonist, methoxamine, which morphologically are 
identical to NE-induced lesions. These are also completely 
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prevented by phentolamine (126). Thus it appears that 
activation of alpha-receptors is the primary pathway 
mediating catecholamine injury. 
There is substantial evidence regarding the existence of 
alpha receptors in the myocardium as well as in the coronary 
arteries (150), the precise mechasnism by which alpha 
activation contributes to lesion formation is unclear. 
Myocardial alha-receptor stimulation is known to result in 
augmented inotropic state (151) as well as in 
vasoconstriction (152). This again raises the possibility 
of mechanical damage as well as ischemic injury secondary to 
a supply-demand mismatch involving increased MV02 and 
vasoconstriction. Vatner et al. (152) demonstrated that NE 
infusion in conscious dogs results in elevated coronary 
resistance, which is prevented by alpha blockade. 
Therefore, NE may cause the myofiber damage by altering 
coronary blood flow. The present study was designed to test 
this hypothesis and to assess the dynamics of coronary flow 
and resistance changes during a NE infusion. 
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CHAPTER THREE 
NOREPINEPHRINE INDUCED CARDIOMYOPATHY 
1 Methods 
Coronary blood flow data were obtained from 15 New 
Zealand white rabbits. All animals were anesthesized with 
phenobarbital, 30 mg/kg, intubated and placed on a Harvard 
respirator. Arterial blood samples were obtained at frequent 
intervals and appropriate adjustments were made to maintain 
pH and PC02 at physiologic values (pH - 7.34-7.44, PC02 - 
34-44 mmHg and P02 above 85 mmHg) throughout each 
experiment. Polyethylene catheters were placed in a femoral 
artery and vein. Arterial pressure was continuously 
measured with a Sanborn transducer and heart rate was 
determined with a Sanborn cardiotachometer. The heart rate 
was verified by manual assessement of pulse frequency from 
pressure traces inscribed by a Sanborn (Model 358) recorder. 
Body temperature was maintainerd with a heating pad. A 
median thoracotomy was performed and the heart was exposed 
and suspended in a pericardial cradle. A polyethylene 
catheter was placed into the left atrium for injection of 
radioactive microspheres. A femoral arterial line was used 
for collecting an arterial reference blood during 
microsphere injection. 
Coronary blood flow was assessed by administration of 
differently labeled radioactive microspheres at specified 
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times during the experiment. Approximately 800,000 
microspheres, 15^ each, labeled with either Ce-141, Ru-103, 
or Sc-46 (New England Nuclear) were injected into the left 
atrium. Prior to each microsphere injection the mixture was 
ultrasonicated and a Harvard withdrawl pump was started (7.5 
ml/min) to collect a reference blood sample. This was 
continued for two minutes after each injection. Upon 
completion of the experiment, the heart was excized and 
epicardial fat, blood vessels and atria were dissected away. 
Each heart was cut into three or four concentric rings in a 
plane parallel to the atrioventricular groove, and each ring 
was then cut into two transmural segments. Each transmural 
segment was then divided into epicardial and endocardial 
halves. All tissue and reference blood samples were counted 
in a gamma well counter (Beckman Gamma 8000). The net 
activity of each isotope was obtained by conventional 
correction for background, energy overlap, and decay due to 
counting. Isotopic activity from the arterial reference 
blood was used to calculate blood flow (ml/mg/min) for each 
myocardial tissue sample. 
An additional group of 10 animals was used to evaluate 
the degree of damage histologically. Each animal in this 
group has received a 90-minute infusion of norepinephrine 
with or without pretreatment with phentolamine. 48 hours 
later animals were sacrificed and several transmural 
myocardial sections were obtained for histological study. A 
previously developed grading scale (116) was used (0 - no 
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damage; 0.5 - injury limited to subendocardium; 1 - injury 
affecting one half of the wall thickness; 1.5 - almost 
transmural injury sparring subepicardium; 2 - transmural 
injury). Each histological section was read by two 
independent observes, each observer assigning a score to 
each section. The scores were avereged and a mean score of 
the two observes was assigned to each animal. 
All results were expressed as mean +/- standard error. 
All hemodynamic and flow data were evaluated by analysis of 
variance. A Bonferroni correction (153) for multiple 
comparisons was made to evaluate significance. The Student 
t test (154) was used when two groups of unpaired data were 
compared. Difference was considered significant when P < 
0.05 
Protocol 
Norepinephrine (Levophed, Winthrop) was freshly prepared 
by dilution in normal saline to concentration which provided 
the dose of 3 yvig/kg/min when infused at constant rate of 
0.382 ml/min. In a group of 5 animals (Group 1) baseline 
coronary flow was obtained with injection of Ce-141 
microspheres. An i.v. infusion of norepinephrine was started 
and two additional sets of microspheres (Ru-103 and Sc-46) 
were injected at 3 and 10 minutes respectively after the 
beginning of norepinephrine infusion. 
In another group of 5 animals (Group 2) a similar 
protocol was utilized except that after obtaining baseline 
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coronary flow, another set of microspheres was injected 40 
minutes after the norepinephrine infusion was started. 
An additional group of 3 animals (Group 3) was given 10 
mg of phentolamine (Regitine, Ciba-Geigy) i.v. over two 
minutes, after the baseline coronary flow was obtained. 
Norepinephrine infusion was started 10 minutes after the 
phentolamine injection, and two more sets of microspheres 
were injected 20 and 40 minutes after beginning the 
norepinephrine infusion. 
In two more animals (Group 4), 0.9% saline was infused 
i.v. and the radioactive microspheres were infused at 0, 20, 
40 minutes after the beginning of saline infusion. 
Two additional groups of 5 animals were used to 
morphologically evaluate the degree of induced injury. 5 
animals (Group 5) received 90-minute NE infusion (3 
j«^g/kg/min) . Another 5 animals (Group 6) received a similar 
90-minute NE after pretreatment with phentolamine (10 mg). 
Substantial alterations in arterial pressure and heart 
rate occured during norepinephrine administration. Maximal 
changes and integrated mean values were obtained at frequent 
intervals. The pressure rate product was calculated as an 
index of metabolic demand. 
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2 RESULTS 
2.1 Hemodynamic data 
Arterial pressure and heart rate changes that occured at 
different time intervals during the infusion of NE (3 
ig/kg/min) alone or with phentolamine (10 mg) are summarized 
in Table 1. Initial values for blood pressure avereged 104 + 
5.8 mmHg in Group 1 animals and 92 + 5.6 mmHg in Group 2 
animals. Initial heart rates were 271 + 14 and 268 + 6 
respectively. Three minutes after the NE infusion was 
started, the blood pressure rose sharply and heart rate 
slowed. With continuous infusion of NE, blood pressure 
gradually declined and heart rate increased to baseline 
levels. At no point did the pressure-rate product exceed the 
baseline values and differences did not reach statistical 
significance (Fig.l). Thus excessive metabolic demand was 
not a significant factor in the development of catecholamine 
cardiomyopathy. 
In the group of animals given phentolamine before the NE 
infusion was started (Group 3), there was no change in the 
heart rate or the blood pressure throughout the infusion 
(Table 1). The pressure-rate product remained nearly 
constant (Fig.2). 
In two control animals infused with saline for 40 minutes 
(Group 4) no significant changes in heart rate or blood 
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pressure occured during the time of infusion (Table 1). 
2.2 Blood flow data 
Coronary blood flow data and calculated coronary 
resistance data for all animals are summarized in Table 2. 
Coronary flow was initially 2.66 cc/gm/min and rose to 3.46 
cc/gm/min three minutes after the NE infusion was started. 
By ten minutes of infusion, flow was back to baseline 
values. At 40 miunutes flow was 1.51 cc/gm/min, 43% lower 
than baseline value (p< 0.01) (Fig 3). Calculated coronary 
resistance was slightly, but not significantly elevated 
three minutes after the beginning of NE infusion. At ten 
minutes, coronary resistance was significantly higher than 
baseline. By 40 minutes it had increased by 83% (p<0.01) 
(Fig 4). 
Phentolamine given before the beginning of NE infusion 
prevented both the decline in coronary blood flow and the 
rise in the calculated coronary vascular resistance. Fig 5 
summarizes coronary flow and Fig 6 coronary resistance data 
in these animals. Thus, alpha blockade with phentolamine 
prevented any significant changes in either coronary flow or 
coronary resistance. The time course of coronary flow 
changes is summarized in Fig 7, and coronary resistance in 
Fig. 8. 
Saline controls showed no change in either coronary flow 
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or coronary resistance throughout the infusion (Table 2). 
2.3 Histological data 
Although the data presented above demonstrates that 
pretreatment with phentolamine prevents NE-induced decline 
in coronary flow and rise in calculated coronary vascular 
resistance, it is still necessary to show that phentolamine 
reduces the severity of NE-induced histological injury. 
Histological damage scores in phentolamine-pretreated or not 
pretreated animals are presented in Fig 9. The mean injury 
score in Group 5 (NE alone) animals was 1.9. Pretreatment 
with phentolamine resulted in marked reduction of the mean 
injury score to 0.5 (p<0.01). Fig 10 demonstrates a typical 
histological section from a Group 5 animal. Severe 
myocardial necrosis with mononuclear cell infiltrate and 
extensive vacuoalizations are evident. These lesions were 
widespread and involved the entire thickness of the 
myocardium. In contrast to this is a histological section in 
Fig 11, typical of Group 6 (phentolamine pretreated) 
animals. Here the injury is limited to subendocardium with 
less extensive necrosis cellular infiltrate and 
vacuolization than in Fig 9. Fig 12 shows a border zone 
between the injured and undamaged myocardium. Thus, alpha 
blockade resulted in marked reduction in the degree of 
histological damage produced by ME administration. 
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2.4 Critique of technique 
In order to obtain meaningful blood flow estimates using 
radioactive microspheres certain conditions should be met. 
These include an adequate sample weight, good microsphere 
mixing and stable microsphere activity in the blood at the 
time when the reference blood sample is obtained. The 
volume of the reference blood sample should be small in 
comparison to the total animal blood volume so that its 
withdrawl does not result in acute hemodynamic changes. All 
these conditions are easily met in dogs, the species for 
which the microsphere technique was first developed. The 
rabbit model, however, presents a more difficult problem. 
First of all, the heart size is small, and only a few pieces 
(6-8) of an acceptable weight can be obtained. Hence, no 
I meaningful separation into endo- and epicardial flow 
components could be done. Secondly, the small volume of the 
1 
j left atrium requires that the volume of administered 
I microspheres also be small. Thish can create problems with 
j j microspheres precipitating in the injection syringe. 
! Thirdly, a total of 45 cc are needed for three reference 
i 
I blood samples. This amount constitutes a significant 
j proportion of the total blood volume. However, if the bloof 
1 withdrav/l is continued over two minutes, and an equal amount 
.) 
l 
of warm saline is infused back into the animal after the 
I 
withdrawl of the first sample, no significant hemodynamic 
; changes occur. Data from control animals infused with 
saline confirms that the technique does not alter the 
I 
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magnitude of coronary flow. 
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5 DISCUSSION 
The results of this study indicate that continuous 
infusion of NE into the rabbit caused a gradual increase of 
calculated coronary resistance, which became significant 10 
minutes after beginning the infusion. This persisted for as 
long as the infusion was continued. In contrast to the 
steady rise in resistance, coronary flow behaved somewhat 
differently. At first, a substantial rise in flow was 
observed which coincided with an increase in the coronary 
perfusion pressure. At this time coronary resistance was 
esentially unchanged. As the infusion was continued, blood 
pressure and, hence, coronary perfusion pressure gradually 
declined, while coronary resistance increased. After 10 
minutes of infusion, coronary flow returned to normal, and 
by 40 minutes was significantly reduced. 
Myocardial oxygen demand (MV02) as assessed by the 
pressure-rate product (PxR) remained unchanged throughout 
the experiments. The PxR product has been shown to 
accurately reflect changes in MV02 under a variety of 
experimental conditions and interventions (155). In a recent 
study of MV02 consumption parameters in closed ches dogs 
different indices were tested under uniform conditions with 
maximal variations in hemodynamics and MV02. In this study 
the PxR product was found to have a correlation coefficient 
of 0.86 when compared to direct measurements of MV02 (155). 
Hence this measure can be considered a valid measure of MV02 

72 
even under extreme circumstances. Since this parameter 
remained stable throughout these experiments it is unlikely 
that excessive metabolic demand was a significant factor in 
the observed coronary blood flow changes. 
It has been recently demonstrated that pretreatment of 
animals with the alpha blocker, phentolamine, prevented the 
development of NE induced damage (126). Furthermore, 
phentolamine prevented a pure alpha agonost, methoxamine, 
from inducing the lesions (126). Thus, it appears likely 
that the lesions of catecholamine cardiomyopathy develop as 
a result of activation of the alpha adrenergic system. 
There exists compelling data regarding the presence of 
alpha receptors on myocytes as well as smooth muscle cells 
of the coronary arteries. Das and Parratt (156) 
demonstrated that infusion of phentolamine in cats resulted 
in increased heart rate, cardiac output, and dP/dt max, 
while pretreatment with reserpine prevented these changes. 
Dairman et al. (157) demonstrated increased synthesis and 
release of cardiac NE caused by phentolamine administration, 
presumably due to phentolamine blockade of alpha-2 receptors 
(158). 
Methoxamine has been shown to induce positive inotropic 
effects producing dose-related increase in force development 
in cat right ventricular papillary muscle (159). This agent 
has been also shown to result in significantly increased 
dP/dt max in lambs (160). Furthemore, alpha receptors have 
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been demonstrated by direct binding studies in rat (161,162) 
and guinea pig myocardium (163). 
In view of these findings one possible mechanism of 
catecholamine injury would be overactivation of the 
myocardial alpha adrenergic system resulting in "mechanical" 
damage. This mechanism would be consistent with a direct 
damage hypothesis discussed previously. 
But on the other hand, alpha receptors have been 
demonstrated in coronary arteries (164), and several 
investigators have described coronary flow and resistance 
changes resulting from NE administration. Thus Vatner et 
al. (152) in studies on conscious dogs found that 
administration of NE (1 |Mg/kg) resulted in an initial drop 
in coronary resistance, followed one minute later by a 
significant rise. Alpha blockade with phentolamine prevented 
the late vasoconstriction and the initial vasodilation was 
not observed in anesthetized animals. Warltier et al. (165) 
using isolated dog heart preparation in which total coronary 
flow was maintained constant, found that administration of 
NE (2 g/kg) resulted in reduced subendocardial flow and a 
drop in the endo/epi flow ratio. 
Kelley and Feigl (166) admistered intracoronary boluses 
of NE to anesthetized open chest dogs. They found an 
increase in total coronary resistance, of v/hich 60% resulted 
from constriction of the large coronary vessels. To confirm 
that alpha adrenergic stimulation results in constriction of 
V 
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both large and small coronary vessels, Vatner et al. studied 
eight consciuos dogs instrumented with ultrasound crystals 
around major coronary arteries. Administration of 
methoxamine (50 ^ g/kg) to these animals resulted in a 92% 
rise in calculated total coronary resistance. A similar rise 
(108%) was observed in large vessel resistance, confirming 
the fact that alpha-mediated vasoconstriction occurs 
throughout the coronary bed (167). 
Similar effects of NE on coronary flow have also been 
observed in humans. Administration of tyramine to six 
patients resulted in increased plasma levels of NE, while 
plasma levels of epinephrine remained stable. In 5 out of 6 
patient a rise in the calculated coronary resistance and a 
concomitant drop in coronary blood flow was observed (168). 
In all patients the PxR product remained constant. 
These data indicate that NE is capable of considerably 
influencing coronary flow and resistance. Thus, it is 
possible that catecholamine cardiomyopathy is induced by 
changes in coronary flow (see ischemic hypothesis in the 
previous section). However, it remained to be demonstrated 
that coronary flow changes induced by NE are of sufficient 
magnitude and duration to result in changes observed in 
cardiomyopathic hearts. Furthermore, since phentolamine 
blockade in known to prevent the lesion production, it 
should also prevent changes in coronary blood flow and 
resistance if these changes are to be considered of 
s 
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pathogenic significance. The results of this study support 
this hypothesis. First it was demostrated that NE given in 
concentrations known to result in morphological damage 
produced a significant fall in coronary flow and increased 
coronary resistance. Both of these changes were observed as 
late as 40 minutes after the beginning of NE infusion. 
Phentolamine given prior to the beginning of NE infusion 
prevented changes in both coronary resistance and flow. 
On the basis of these findings it appears likely that NE 
induces damage, at least in part, by altering coronary blood 
flow. It should be pointed out, however, that this study 
does not rule out the possibility that some of the damage is 
induced by alterting the inotropic state of the myocardium. 
Quite possibly both of these mechanisms contribute. 
As has been noted in the discussion of pathology, lesions 
of catecholamine cardiomyopathy tend to predominate in the 
subendocardium. It is reasonable to expect any substance 
affecting coronary blood flow to cause the most damage in 
the subendocardium, as is observed with NE infusion. 
However, it is also pssible that NE is itself capable of 
altering the endo/epi flow ratio. The data in this regard 
are conflicting. Warltier et al. (165) observed a decline 
in the endocardial flow and the endo/epi flow ratio in 
isolated dog heart preparation in which the total coronary 
flow was maintained constant. On the other hand, Dumount 
and Lelorier (169) using acute dogs observed an insignifi- 
s 
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cant rise in the endo/epi flow ratio. Bolli et al. (170) 
studying methoxamine infusion in acute dogs observed a rise 
in the endo/epi flow ratio. As has been noted in the 
section on Results, the technical limitations of the rabbit 
model did not allow a separate dermination of endocardial 
and epicardial coronary flow components. This matter, 
therefore, will require further work. 
It is interesting to speculate on how NE alters coronary 
flow and whether alpha mediated vasoconstriction is the only 
mechanism involved. As has been discussed in the section on 
coronary flow regulation, adenosine appears to be the major 
metabolite responsible for active coronary vasomotion. 
Adenosine is known to antagonise catecholamine effects on 
the myocardium. Thus, adenosine administration decreases 
isoproterenol induced rises in cAMP, protein kinase and 
phosphorylase in myocytes (171,172). It has also been shown 
to decrease dP/dt max and rate of ventricular relaxation 
(172). Thus adenosine may share a common receptor(s) with 
NE. 
It is also known that catecholamine administration 
results in increased release of adenosine from the 
myocardium. This effect is short-lived, however. In studies 
on isolated guinea pig hearts, norepinephrine infusion 
resulted in increased adenosine release which peaked at four 
minutes. After ten minutes of infusion, adenosine levels 
declined (173). This time course of adenosine concentration 
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changes corresponds closely to changes in coronary flow 
observed in this study where a considerable rise was 
observed at 3 minutes with flow returning to normal by 10 
minutes. It can be speculated that NE-adenosine interaction 
is responsible for the flow changes during the first ten 
minutes of catecholamine administration. Later, as the 
protective effect of adenosine wears off, alpha-mediated 
vasoconstriction becomes predominant and coronary flow 
falls. 
In summary, this study has demonstrated that NE 
administration in doses known to induce typical 
catecholamine cardiomyopathy, results in substantial 
alterations of both coronary blood flow and resistance. 
Myocardial oxygen demanded as assessed by the PxR product 
remained unchanged and probably did not play any 
pathogenetic role. Administration of an alpha blocker, 
phentolamine, prevented changes in both coronary flow and 
resistance. It is concluded that NE causes myocardial injury 
in part by decreasing coronary blood flow due to induced 
vasoconstriction. It is possible that adenosine temporarily 
opposes these effects of NE. But if the NE infusion is 
continued for a sufficient length of time, alpha-mediated 
vasoconstriction becomes predominant and the ischemic damage 
results. 
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Table 2 
Coronary blood flow and resistance in response to various agents indicated. 
Norepinephrine NE + Ph Saline 
T CBF CR T CBF CR T CBF CR 
0 2.66 40.9 0 2.66 43.7 0 2.69 39.2 
+ .23 +2.6 + .18 +2.6 + .07 +2.8 
3 3.46* 43.1 20 2.94 35.4 20 2.58 37.3 
+ .07 +1.5 + .30 +2.4 + .07 ±•7 
10 2.33 50.5* 40 2.24 50.0 40 2.69 33.3 
+ .15 +2.8 + .33 +4.6 +0.9 +3.3 
40 1.51* 74.8* 
+.12 +^9.1 
*P < 0.05 
T, time (min); CBF, Coronary blood flow (ml/min/gm); CR, coronary resistance 
(mnilg/ml/min); Ph, phentolamine (10 mg). 
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FIGURE 1 
NE 
Heart rate (HR) - blood pressure (BP) product (units) 
measured at four time intervals in animals infused with 
norepinephrine (NE). Vertical brackets indicate SEM. 
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FIGURE 2 
TIME (min) 
Heart rate (HR) - blood pressure (BP) product (units) 
measured at three time intervals in phentolamine (Ph) 
pretreated animals. Vertical brackets, SEM. 
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FIGURE 3 
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Coronary blood flow (CBF), cc/g/min, measured at four time 
intervals in a group of animals infused with NE. Vertical 
brackets, SEM. 
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FIGURE 4 
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FIGURE 5 
NOREPINEPHRINE + PHENTOLAMINE 
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FIGURE 6 
NOREPINEPHRINE+ PHENTOLAMINE 
Coronary resistance (CR), 
pretreated with phentolamine. 
mm Hg/cc/g/min, in animals 
Vertical brackets, SEM. 
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FIGURE 7 
EFFECTS OF ALPHA BLOCKADE 
TIME (min) 
Coronary blood flow (CBF) at different time intervals in 
animals pretreated (open circles) and not pretreated (closed 
circles) with phentolamine. Vertical brackets, SEM. 
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FIGURE 8 
EFFECTS OF ALPHA BLOCKADE 
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Coronary resistance (CR) at different time intervals in 
phentolamine pretreated (open circles) and not pretreated 
(closed circles) animals. Vertical brackets, SEM. 
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FIGURE 9 
HISTOLOGICAL DAMAGE 
(48 hrs) 
(n=5) {n=5) 
Histogram of histological injury scores. NE-treated animals- 
left bar, NE+Ph treated animals- right bar. Vertical 
brackets, SEM. 
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FIGURE 10 
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Microphotograph of myocardial section from a rabbit 
sacrificed 48 hrs after ME infusion (3 g/kg/min). H & E 
stain. Original magnification, x400. 
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FIGURE 11 
* V 
*s 
j ‘t 
Microphotograph of myocardial section from a rabbit 
pretreated with phentolamine and sacrificed 48 hrs after NE 
infusion (3 g/kg/min). H & E stain. Original 
magnification, x400. 
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FIGURE 12 
Microphotograph of myocardial section from a rabbit 
pretreated with phentolamine and sacrificed 48 hrs a ter NE 
infusion (3 g/kg/min). Border zone between undamaged and 
damaged tissues. H & E stain. Original magnification, x400. 
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